Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDICLIN AG Major Shareholding Notification 2009

Apr 29, 2009

280_rns_2009-04-29_3a1a364e-4d42-42a1-bd30-2c8abca80829.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

News Details

Corporate | 29 April 2009 09:32

Asklepios increased the share in MediClin up to 20.2%

MediClin AG / Miscellaneous

Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.


Frankfurt, April 29, 2009 - The Management of Asklepios informed us today,
that they increased the share in MediClin up to 20.2%. The shareholding in
MediClin shall support Asklepios to that effect that it will strengthen
it's leading position in the health care market. The MediClin-Model of
Integrated Medical Care across medical sector borders gains more and more
acceptance in the health care industry, not only with cost providers also
with other clinic operators. MediClin is convinced that integrated care as
market- and patient-driven medical service offering will be one of the key
issues of the future health care service concepts.

About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neurosciences as well as Orthopaedic. With 33
clinics and 8 nursing care facilities and 3 Medizinische Versorgungszentren
(medical care units) in 11 federal states MediClin at the year end of 2008
it has a total capacity of approximately 7,900 beds. MediClin's facilities
include acute care clinics, i.e., general hospitals, special treatment
facilities, specialised hospitals and clinics for post-acute treatment and
medical rehabilitation. MediClin has approximately 7,800 employees.
29.04.2009 Financial News transmitted by DGAP


Language: English
Issuer: MediClin AG
Westhafenplatz 1
60327 Frankfurt
Deutschland
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: [email protected]
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Stuttgart, München, Hamburg, Düsseldorf

End of News DGAP News-Service